Prednisone-neostigmine interactions at cholinergic junctions
- 1 March 1979
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 2 (2) , 155-157
- https://doi.org/10.1002/mus.880020210
Abstract
The effect of corticosteroid (prednisone) and/or chronic anticholinesterase (neostigmine) treatment on α‐bungarotoxin binding was examined in the diaphragms of male rats. In endplate regions of the diaphragm, prednisone treatment had no effect on the density of toxin binding sites, either when given alone or when administered in conjunction with neostigmine, while neostigmine was observed to reduce specific binding to less than half after one week.This publication has 8 references indexed in Scilit:
- Antimyasthenic Action of CorticosteroidsArchives of Neurology, 1977
- Neostigmine MethylsulfateArchives of Neurology, 1975
- Study of long‐term anticholinesterase therapyNeurology, 1973
- Influence of chronic neostigmine treatment on the number of acetylcholine receptors and the release of acetylcholine from the rat diaphragmThe Journal of Physiology, 1973
- Binding of α-Bungarotoxin to Acetylcholine Receptors In Mammalian MuscleProceedings of the National Academy of Sciences, 1972
- Chromatographic separation of the venom of Bungarus multicinctus and characterization of its componentsJournal of Chromatography A, 1972
- Acetylcholine release from motor-nerve endings in rats treated with neostigmineEuropean Journal of Pharmacology, 1969
- An enzymic method for the trace iodination of immunoglobulins and other proteinsBiochemical Journal, 1969